| Literature DB >> 25259408 |
Jiemiao Hu1, Jun Yan1, Ganesh Rao2, Khatri Latha2, Willem W Overwijk3, Amy B Heimberger2, Shulin Li1.
Abstract
Fibrinogen-like protein 2 (Fgl2), a member of the fibrinogen family, can be expressed as a membrane-associated protein with coagulation activity or in a secreted form possessing unique immune suppressive functions. The biological importance of Fgl2 is evident within viral-induced fibrin depositing inflammatory diseases and malignancies and provides a compelling rationale for Fgl2 expression to not only be considered as a disease biomarker but also as a therapeutic target. This article will provide a comprehensive review of the currently known biological properties of Fgl2 and clarifies future scientific directives.Entities:
Keywords: DC maturation; Tregs; fibrin deposit; glioblastoma; immune suppression; inflammatory diseases; liver injury; membrane-bound procoagulant; secreted immune checkpoint regulator
Mesh:
Substances:
Year: 2014 PMID: 25259408 PMCID: PMC5257246 DOI: 10.3109/08830185.2014.956360
Source DB: PubMed Journal: Int Rev Immunol ISSN: 0883-0185 Impact factor: 5.311